Binding of transcription factors to widely-separated cis-regulatory elements of the murine FGF-4 gene

Molecular Reproduction and Development

Volumn 44, Issue 4, 1996, Pages 460-471

  Lamb, Kimberly ^a,b   Rosfjord, Edward ^a,b,c   Brigman, Kristen ^a   Rizzino, Angie ^a,b  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^b UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^c GEORGETOWN UNIVERSITY   (United States)

Author keywords

Differentiation; Embryonal carcinoma cells; Embryonic Stem Cells; HMG Binding proteins; Octamer binding proteins; Sp1

Indexed keywords

FIBROBLAST GROWTH FACTOR 4; HIGH MOBILITY GROUP PROTEIN; RETINOIC ACID; TRANSCRIPTION FACTOR SP1; TRANSCRIPTION FACTOR SP4; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL DIFFERENTIATION; CONTROLLED STUDY; DNA FLANKING REGION; EMBRYO; EMBRYONAL CARCINOMA; GENE EXPRESSION REGULATION; GENE LOCATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; REGULATOR GENE; REPRESSOR GENE; TRANSCRIPTION REGULATION;

ANIMALS; BIOPOLYMERS; CELLS, CULTURED; ENHANCER ELEMENTS (GENETICS); FIBROBLAST GROWTH FACTOR 4; FIBROBLAST GROWTH FACTORS; MICE; NUCLEAR PROTEINS; PROTEIN BINDING; PROTO-ONCOGENE PROTEINS; REGULATORY SEQUENCES, NUCLEIC ACID; TRANSCRIPTION FACTORS; TUMOR CELLS, CULTURED;

ANIMALIA; MURINAE;

EID: 0029745361     PISSN: 1040452X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-2795(199608)44:4<460::AID-MRD5>3.0.CO;2-J     Document Type: Article

References (56)

1. Annweiler A, Müller-Immerglück M, Wirth T (1992): Oct2 transactivation from a remote enhancer position requires a B-cell-restricted activity. Mol Cell Biol 12:3107-3116.
2. Bryans M, Lucas J, Knoblock T, Wilkie N, Lang J (1995): Regulation of FGF-4 of enhancer activity by transcription factor HF-Y. Biochem Biophys Res Commun 211:5619-527.
3. Bundgaard JR, Hansen TVO, Friss-Hansen L, Rourke IJ, van Solinge WW, Nielsen FC, Rehfeld JF (1995): A distal Sp1-element is necessary for maximal activity of the human gastric gene promoter. FEBS Lett 369:225-228.
4. Chan D, Wynshaw-Boris A, Leder P (1995): Formin isoforms are differentially expressed in mouse embryo and are required for normal expression of FGF-4 and SHH in the limb bud. Development 121: 3151-3162.
5. Courey AJ, Hotzman DA, Jackson SP, Tjian R (1989): Synergistic activation by the glutamine-rich domains of human transcription factor Sp1. Cell 59:827-836.
6. Curatola AM, Basilico C (1990): Expression of the K-fgf proto-oncogene is controlled by 3′ regulatory elements which are specific for embryonal carcinoma cells. Mol Cell Biol 10:2475-2484.
7. Dailey L, Yuan H, Basilico C (1994): Interaction between a novel F9-specific factor and octamer-binding proteins is required for cell-type-restricted activity of the fibroblast growth factor 4 enhancer. Mol Cell Biol 14:7758-7769.
8. Darrow AL, Rickles RJ, Pecorino LT, Strickland S (1990): Transcription factor Sp1 is important for retinoic acid-induced expression of the tissue plasminogen activator gene during F9 teratocarcinoma cell differentiation. Mol Cell Biol 10:5883-5893.
9. Dennig J, Hagen G, Beato M, Suske G (1995): Members of the Sp1 transcription factor family control transcription from the uteroglobin promoter. J Biol Chem 270:12737-12744.
10. Dignam JD, Lebovitz RM, Roeder RG (1983): Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. Nucleic Acids Res 11:1475-1489.
11. Doetschman TC, Eistetter H, Katz M, Schmidt W, Kemler R (1985): The in vitro development of blastocyst-derived embryonic stem cell lines: Formation of visceral yolk sac, blood islands and myocardium. J Embryol Exp Morphol 87:27-45.
12. Feldman B, Poueymirou W, Papaiannou VE, DeChiara TM, Goldfarb M (1995): Requirement of FGF-4 for postimplantation mouse development. Science 267:246-249.
13. Fried M, Croters DM (1981): Equilibria and kinetics of lac repressor-operator interactions by polyacrylamide gel electrophoresis. Nucleic Acids Res 9:6505-6525.
14. Hagen G, Müller S, Beato M, Suske G (1994): Sp1-mediated transcriptional activation is repressed by Sp3. EMBO J 13:3843-3851.
15. Hasan S, Koda T, Kakinuma M (1994): An upstream NF-Y-binding site is required for transcriptional activation from the hst promoter in F9 embryonal carcinoma cells. J Biol Chem 269:25042-25048.
16. Heath JK, Isake CM (1984): PC13 embryonal carcinoma-derived growth factor. EBMO J 3:2957-2962.
17. Hinkley C, Perry M (1992): Histone H2B gene transcription during Xenopus early development requires functional cooperation between proteins bound to the CCAAT and octamer motifs. Mol Cell Biol 12: 4400-4411.
18. Imagawa M, Miyamoto A, Shirakawa M, Hamada H, Muramatsu M (1991): Stringent integrity requirements for both trans-activation and DNA binding in a trans-activator, Oct-3, Nucleic Acids Res 19:4503-4508.
19. Kelly D, Scholtz B, Orten D, Hinrichs S, Rizzino A (1995): Regulation of the transforming growth factor-β2 gene promoter in embryonal carcinoma cells and their differentiated cells: Differential utilization of transcription factors. Mol Reprod Dev 40:135-145.
20. Koda T, Hasan S, Sasaki A, Arimura Y, Kakinuma M (1994): Regulatory sequences required for hst-1 expression in embryonal carcinoma cells. FEBS Lett 342:71-75.
21. Ma Y-G, Rosfjord E, Huebert C, Wilder P, Tiesman J, Kelly D, Rizzino A (1992): Transcriptional regulation of the murine k-FGF gene in embryonic cell lines. Dev Biol 154:45-54.
22. Mastrangelo IA, Courey AJ, Wall JS, Jackson SP, Hough PVC (1991): DNA looping and Sp1 multimer links: a mechanism for transcriptional synergism and enhancement. Proc Natl Acad Sci USA 88:5670-5674.
23. Meijer D, Graus A, Kraay R, Langeveld A, Mulder MP, Grosveld G (1990): The octamer binding factor Oct6: cDNA cloning and expression in early embryonic cells, Nucleic Acids Res 18:7357-7365.
24. Miller K, Rizzino A (1994): Developmental regulation and signal transduction pathways of fibroblast growth factors and their receptors. In M Nilsen-Hamilton (ed): "Growth Factors and Signal Tansduction in Development." New York: Wiley-Liss, Inc., pp 19-49.
25. Niswander L, Martin G (1992): FGF-4 expression during gastrulation, myogenesis, limb and tooth development in the mouse. Development 114:755-768.
26. Niswander L, Tickle C, Vogel A, Martin G (1994): Function of FGF-4 in limb development. Mol Reprod Dev 39:83-89.
27. Ochiya T, Sakamoto H, Tsukamoto M, Sugimura T, Terada M (1995): Hst-1 (FGF-4) antisense oligonucleotides block murine limb development. J Cell Biol 130:997-1003.
28. Okamoto K, Okazawa H, Okuda A, Sakai M, Muramatsu M, Hamada H (1990): A novel octamer binding transcription factor is differentially expressed in mouse embryonic cells. Cell 60:461-472.
29. Okazawa H, Okamoto K, Ishino F, Ishino-Kaneko T, Takeda S, Toyoda Y, Muramatsu M, Hamada H (1991): The Oct3 gene, a gene for an embryonic transcription factor, is controlled by a retinoic acid repressible enhancer. EMBO J 10:2997-3005.
30. Pascal E, Tjian R (1991): Different activation domains of Sp1 govern formation of multimers and mediate transcriptional synergism. Genes Dev 5:1646-1656.
31. Peters G, Brookes S, Smith R, Placzek M, Dickson C (1989): The mouse homolog of the hst/k-FGF gene is adjacent to int-2 and is activated by proviral insertion in some virally induced mammary tumors. Proc Natl Acad Sci USA 86:5678-5682.
32. Rappolee DA, Sturm K, Schultz G, Pedersen R, Werb Z (1990): Expression of growth factor ligands and receptors in preimplantation mouse embryos. In S Heyner, L Wiley (eds): "Early Embryo Development and Paracrine Realtionships." New York: Wiley-Liss, Inc., pp 11-25.
33. Renner K, Leger H, Wegner M (1994): The POU domain protein Tst-1 and papoviral large tumor antigen function synergistically to stimulate glia-specific gene expression of JC virus. Proc Natl Acad Sci USA 91:6433-6437.
34. Rizzino A (1989): Use of embryonal carcinoma cells to study growth factors during early mammalian development. In IY Rosenblum, S Heyner (eds): "Growth Factors in Mammalian Development." Boca Raton: CRC Press, Inc., pp 113-134.
35. Rizzino A, Rosfjord E (1994): Transcriptional regulation of the murine k-FGF gene. Mol Reprod Dev 39:106-111.
36. Rizzino A, Orme LS, De Larco JE (1983): Embryonal carcinoma cell growth and differentiation: Production of and response to molecules with transforming growth factor activity. Exp Cell Res 143:143-152.
37. Rizzino A, Kuszynski C, Ruff E, Tiesman J (1988): Production and utilization of growth factors related to fibroblast growth factor by embryonal carcinoma cells and their differentiated cells. Dev Biol 129:61-71.
38. Rosfjord E, Rizzino A (1994): The octamer motif present in the REX-1 promoter binds Oct-1 and Oct-3 expressed by EC cells and ES cells. Biochem Biophys Res Commun 203:1795-1802.
39. Rosner MH, Vigano MA, Ozato K, Timmons PM, Poirier F, Rigby PWJ, Staudt LM (1990) : A POU-domain transcription factor in early stem cells and germ cells of the mammalian embryo. Nature 345:686-692.
40. Schöler HR, Hatzopoulos AK, Balling R, Suzuki N, Gruss P (1989): A family of octamer-specific proteins present during mouse embryogenesis: Evidence for germline-specific expression of an Oct factor. EMBO J 8:2543-2550.
41. Scholtz B, Kelly D, Rizzino A (1995): Cis-regulatory elements and transcription factors involved in the regulation of the transforming growth factor-μ2 gene. Mol Reprod Dev 41:140-148.
42. Scholtz B, Lamb K, Rosfjord E, Kingsley M, Rizzino A (1996): Appearance of a nuclear protease activity after embryonal carcinoma cells undergo differentiation. Dev Biol 173:420-427.
43. Schoorlemmer J, Kruijer W (1991): Octamer-dependent regulation of the kFGF gene in embryonal carcinoma and embryonic stem cells. Mech Dev 36:75-86.
44. Seipel K, Georgiev O, Schaffner W (1992): Different activation domains stimulate transcription from remote ("enhancer") and proximal ("promoter") positions. EMBO J 11:4961-4968.
45. Shykind BM, Kim J, Sharp PA (1995): Activation of the TFIID-TFIIA complex with HMG-2. Genes Dev 9:1354-1365.
46. Su W, Jackson S, Tjian R, Echols H (1991): DNA looping between sites for transcription activation: Self-association of DNA-bound Sp1. Genes Dev 5:820-826.
47. Suzuki N, Rohdewohld H, Neuman T, Gruss P, Schöler HR (1990): Oct-6: A POU transcription factor expressed in embryonal stem cells and in the developing brain. EMBO J 9:3723-2732.
48. Tiesman J, Rizzino A (1989): Expression and developmental regulation of the k-FGF oncogene in human and murine embryonal carcinoma cells. In Vitro Cell Dev Biol 25:1193-1198.
49. Tiesman J, Rizzino A (1990): Nucleotide sequence of the 5′-flanking region of the mouse k-FGF oncogene exhibits an alternating purine:pyrimidine motif with the potential to form Z-DNA. Gene 96:311-312.
50. Velcich A, Delli-Bovi P, Mansukhani A, Ziff EB, Basilico, C (1989): Expression of the K-fgf protooncogene is repressed during differentiation of F9 cells. Oncogene Res 5:31-37.
51. Wright EM Snopek B, Koopman P (1993): Seven new members of the Sox gene family expressed during mouse development. Nucleic Acids Res 21:744.
52. Wright KL, Moore TL, Vilen BJ, Brown AM, Ting JP-Y (1995): Major histocompatibility complex class II-associated invariant chain gene expression is up-regulated by cooperative interactions of Sp1 and NF-Y. J Biol Chem 270:20978-20986.
53. Yoshida T, Miyagawak K, Odagiri H, Sakamoto H, Little PF, Terada M, Sugimura T (1987): Genomic sequence of hst, a transforming gene encoding a protein homologous to fibroblast growth factors and the int-2-encoding protein. Proc Natl Acad Sci USA 84:7305-7309.
54. Yoshida T, Muramatsu H, Muramatsu T, Sakamoto H, Katoh O, Sugimura T, Terada M (1988): Differential expression of two homologous and clustered oncogenes, Hst1 and Int-2, during differentiation of F9 cells. Biochem Biophys Res Commun 157:618-625.
55. Yuan H, Corbi N, Basilico C, Dailey L (1995): Development-specific activity of the FGF-4 enhancer requires the synergistic action of Sox2 and Oct-3. Genes Dev. 9:2635-2645.
56. Zwilling S, König H, Wirth T (1995): High mobility group protein 2 functionally interacts with the POU domains of octamer transcription factors. EMBO J 14:1198-1208.